Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme - Concepedia

Concepedia

Publication | Closed Access

Bicalutamide (‘Casodex’) 150mg as adjuvant to radiotherapy in patients with localised or locally advanced prostate cancer: Results from the randomised Early Prostate Cancer Programme

71

Citations

20

References

2005

Year

C. Tyrrell, H. Payne, William A. See, David G. McLeod, Manfred P. Wirth, Peter Iversen, J. Armstrong, Clive Morris

Radiotherapy and Oncology

Radiation MedicineUrologyMedicineMetronomic TherapyAdvanced Prostate Cancer‘ Casodex ’Prostatic DiseaseOncologyRadiation Oncology

References

	Year	Citations

Page 1